Cargando…

Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening

Traditional high-throughput drug screening in oncology routinely relies on two-dimensional (2D) cell models, which inadequately recapitulate the physiologic context of cancer. Three-dimensional (3D) cell models are thought to better mimic the complexity of in vivo tumors. Numerous methods to culture...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Shurong, Tiriac, Hervé, Sridharan, Banu Priya, Scampavia, Louis, Madoux, Franck, Seldin, Jan, Souza, Glauco R., Watson, Donald, Tuveson, David, Spicer, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013403/ https://www.ncbi.nlm.nih.gov/pubmed/29673279 http://dx.doi.org/10.1177/2472555218766842

Ejemplares similares

A Novel 3-dimensional High Throughput Screening Approach Identifies Inducers of a Mutant KRAS Selective Lethal Phenotype
por: Kota, Smitha, et al.
Publicado: (2018)

A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons
por: Sridharan, BanuPriya, et al.
Publicado: (2019)

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
por: Pan, Chun‐Hao, et al.
Publicado: (2020)

Dynamic changes during the treatment of pancreatic cancer
por: Wolff, Robert A., et al.
Publicado: (2018)

Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism
por: Hou, Shurong, et al.
Publicado: (2023)

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
por: Madoux, Franck, et al.
Publicado: (2016)

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
por: Somerville, Tim D.D., et al.
Publicado: (2018)

In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma
por: Rajan, Robin G., et al.
Publicado: (2023)

Discovery and Optimization of Selective Inhibitors of Meprin α (Part I)
por: Hou, Shurong, et al.
Publicado: (2021)

Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening
por: Geyer, Marlene, et al.
Publicado: (2021)

Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment
por: Wang, Leiming, et al.
Publicado: (2020)

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer
por: Lee, EunJung, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma Induces Neural Injury that Promotes a Transcriptomic and Functional Repair Signature by Peripheral Neuroglia
por: Weitz, Jonathan, et al.
Publicado: (2023)

Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond
por: Weitz, Jonathan Robert, et al.
Publicado: (2021)

Magnetic bioassembly platforms for establishing craniofacial exocrine gland organoids as aging in vitro models
por: Rodboon, Teerapat, et al.
Publicado: (2022)

High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2
por: Smith, Emery, et al.
Publicado: (2023)

Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias
por: Janovick, Jo Ann, et al.
Publicado: (2017)

Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR
por: Smith, Emery, et al.
Publicado: (2020)

Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
por: Plate, Lars, et al.
Publicado: (2016)

High-throughput scNMT protocol for multiomics profiling of single cells from mouse brain and pancreatic organoids
por: Cerrizuela, Santiago, et al.
Publicado: (2022)

A FluoPol-ABPP PAD2 High-Throughput Screen Identifies the First Calcium Site Inhibitor Targeting the PADs
por: Lewallen, Daniel M., et al.
Publicado: (2014)

Waging war against pancreatic cancer: an interview with David Tuveson
por: Tuveson, David
Publicado: (2017)

Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic
por: Ohman, Kerri A., et al.
Publicado: (2016)

Pancreatic cancer SLUGged
por: Josselsohn, Rachel H., et al.
Publicado: (2020)

Generation of Pancreatic Organoid-Derived Isografts
por: D’Agosto, Sabrina, et al.
Publicado: (2020)

Digitalized Human Organoid for Wireless Phenotyping
por: Kimura, Masaki, et al.
Publicado: (2018)

Phenotypic landscape of intestinal organoid regeneration
por: Lukonin, Ilya, et al.
Publicado: (2020)

Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity
por: Smith, Emery, et al.
Publicado: (2020)

Ectopic Leptin Production by Intraocular Pancreatic Islet Organoids Ameliorates the Metabolic Phenotype of ob/ob Mice
por: Leibiger, Barbara, et al.
Publicado: (2021)

Organoid technology for personalized pancreatic cancer therapy
por: Bengtsson, Axel, et al.
Publicado: (2021)

The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
por: Low, Ronnie Ren Jie, et al.
Publicado: (2021)

An Immersible Microgripper for Pancreatic Islet and Organoid Research
por: Früh, Eike, et al.
Publicado: (2022)

Pancreatic Organoids for Regenerative Medicine and Cancer Research
por: Casamitjana, Joan, et al.
Publicado: (2022)

Organoids in image-based phenotypic chemical screens
por: Lukonin, Ilya, et al.
Publicado: (2021)

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
por: Öhlund, Daniel, et al.
Publicado: (2017)

Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
por: Hohwieler, Meike, et al.
Publicado: (2019)

Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases
por: Liu, Yuxiang, et al.
Publicado: (2023)

Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening
por: Nguyen, Huyen Thi Lam, et al.
Publicado: (2020)

Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids
por: Renner, Henrik, et al.
Publicado: (2021)

High-throughput drug screening of fine-needle aspiration-derived cancer organoids
por: Bergdorf, Kensey, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pgv78ottuj5042o52eo4eu07qi